. 2004 Jun;136(3):501–506. doi: 10.1111/j.1365-2249.2004.02474.x

Table 1.

Patients’ characteristics at baseline (n = 54)

Risk group
IDU^a	25 (46·3)
Homosexual^a	15 (27·8)
Heterosexual^a	14 (25·9)
Sex
Male^a	42 (77·8)
HCV-co-infection^a	26 (48·1)
Age (years)^b	37·0 [29·8–43·3]
Total CD4⁺ count (cells/µl)^b	255·5 [44·0–439·5]
Total CD8⁺ count (cells/µl)^b	756·0 [456·8–977·0]
Naive CD4⁺ count (cells/µl)^b,c	60·2 [7·90–140·5]
Naive CD8⁺ count (cells/µl)^b,^c	45·1 [23·8–116·2]
Memory CD4⁺ count (cells/µl)^b,c	122·8 [41·8–181·0]
Memory CD8⁺ count (cells/µl)^b,^c	248·5 [156·0–491·0]
IL-7 (pg/ml)^b,^c	26·7 [19·5–41·8]
Viral load (log₁₀copies/ml)^b	4·9 [4·4–5·2]
Thymic volume (cm³)^b,^d	3·4 [1·8–6·2]
TREC-bearing cells (cells/µl)^b,^c	0·74 [0·2–2·5]

Number of subjects (percentage);

median (interquartile range);

availab1e in 42 patients;

availab1e in 49 patients. IDU, injecting drug user; HCV, hepatitis C virus; TREC, T cell excision circle.